The result showed that the 5-year DFS rate was lower among patients with PPM1H-negative tumours than patients with PPM1H-high tumours (65.9% vs. 75.0%, P = 0.008) (Fig. 2b). The gene discussed is PPM1H; the disease is neoplasm.